Search Results - "Miles Congreve"

PubPharm (6)

1

A phase 1b/2a multicenter study of the safety and preliminary pharmacodynamic effects of selective muscarinic M1 receptor agonist HTL0018318 in patients with mild‐to‐moderate Alzheimer's disease

in: Alzheimer’s & Dementia: Translational Research & Clinical Interventions | 2022

by Pradeep J. Nathan | S. Babli Millais | Alex Godwood | +12

2

Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M1 receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study

in: Alzheimer’s Research & Therapy | 2021

by Charlotte Bakker | Tim Tasker | Jan Liptrot | +11

3

Perspective in Medicinal Chemistry: Structure-Based Drug Design

in: Current topics in medicinal chemistry | 2017

by Miles Congreve | Steve Andrews

4

Current Topics in Medicinal Chemistry: Editorial (Thematic Issue: New Targets for Structure-Based Drug Discovery)

in: Current topics in medicinal chemistry | 2017

by Steve Andrews | Miles Congreve

5

Intracellular allosteric antagonism of the CCR9 receptor

in: Nature | 2016

by Christine Oswald | Mathieu Rappas | James Kean | +10

6

Current Topics in Medicinal Chemistry: Meet the Editorial Board

in: Current topics in medicinal chemistry | 2015

by Miles Congreve

1
[1]